Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, ...

PMEA returned on 19 November to the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

VML Portugal has announced the launch of VML Health, with pharma communications veteran Mariana Marta dos Santos being ...

Johnson & Johnson (J&J) has received a positive recommendation from the UK’s National Institute for Health and Care ...

For decades, menopause has been swept under the rug, or into the dark corners of clinicians’ offices, often dismissed as ...

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional ...

The career path of a Nurse Practitioner is often envisioned as a straight line: clinical practice, specialization, perhaps a ...

Biogen and Eisai have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an ...

InflaRx – a biopharmaceutical company developing anti-inflammatory therapeutics targeting the complement system – has ...

Gilead has reported that its phase 3 ASCENT-07 trial evaluating Trodelvy (sacituzumab govitecan-hziy) as a first-line ...

Novo Nordisk has reported that its 2.4mg dosage of semaglutide (Wegovy) demonstrated a reduction in liver injury (steatohepatitis) among patients with metabolic dysfunction-associated steatohepatitis ...

Amgen has reported positive results from its phase 3 VESALIUS-CV trial, which demonstrated that Repatha (evolocumab) ...